Page 1 - BC Management ToolCard

Multidisciplinary Management

of Bladder Cancer

Diagnosis Tool

Suspected MIBC

Patient history and physical exam

High quality TURBT Histology Histological type (including mixed histologies)
e.g. urothelial, squamous, small cell carcinoma

Depth of Invasion Depth of tumor invasion into muscularis propria
Referal to patient
information
resources Imaging, Pathology, Grade High/Low
(e.g. Bladder Cancer Staging & Resectability
Canada)
Concomitant CIS/ LVI Evaluation of tumour dissemination/metastasis

Assess need for Hydronephrosis Divergent
renal drainage differentiation of Include variant histology/proportion of variant histology
urothelial carcinoma

Metastatic

YES NO

Significant local symptoms YES Assemble multidisciplinary care conference
or recurrent hematuria

NO

Direct referal to medical oncologist

Contributing Authors: Abbreviations: References:
Aly-Khan Lalani, MD, FRCPC CIS carcinoma in situ Kulkarni et al., Canadian Urological Association guideline: Muscle-invasive bladder cancer, CUAJ. (2019).
Wassim Kassouf, MD, CM, FRCSC LVI lymphovascular invasion
MIBC muscle-invasive bladder cancer
TURBT transurethral resection of bladder tumour
Canadian Urological Association. All rights reserved. October 2022
This tool card has been made possible through funding from Bristol-Myers Squibb in the form of an educational grant. BC-MANAGEMENT-Eng-1500-Oct.2022